Poliovirus isolates of serotypes 2 and 3 from patients whose paralytic poliomyelitis cases were classified as oral vaccine-associated were analysed by oligonucleotide mapping of the virus genomes and by polyacrylamide gel electrophoresis of the virus proteins. Oligonucleotide maps of all isolates were similar to the maps of the corresponding oral vaccine strain. No two isolates gave identical maps. Most maps differed from that of the vaccine strain by at least one oligonucleotide spot. Maps of some isolates revealed numerous differences, indicating that multiple (> 100) genetic changes had occurred in the vaccine virus genomes during replication in one or two individuals. In contrast, maps of some neural tissue isolates showed minimal differences from the reference vaccine maps, raising the possibility that neuro-virulence may be restored by a small number of genetic changes. For many isolates, changes were also detected in the mobilities and processing rates of the virus proteins.
ButterworthB. E.1973; A comparison of the virus-specific polypeptides of encephalomyocarditis virus, human rhinovirus-1A, and poliovirus. Virology 56:439–453
FlaneganJ. B.,
BaltimoreD.1979; Poliovirus polyuridylic acid polymerase and RNA replicase have the same viral polypeptide. Journal of Virology 29:352–360
JarzabekZ.,
SadowskiW.,
KantochM.,
MagrathD.,
KrawczynskiK.1976; Studies on the characteristics of poliovirus type 3. III. Strain characteristics after passage in man. Acta Virologica 20:373–379
KewO. M.,
PallanschM. A.,
OmilianowskiD. R.,
RueckertR. R.1980; Changes in three of the four coat proteins of oral poliovaccine strain derived from type 1 poliovirus. Journal of Virology 33:256–263
LeeY. F.,
KitamuraN.,
NomotoA.,
WimmerE.1979; Sequence studies of poliovirus RNA. IV. Nucleotide sequence complexities of poliovirus type 1, type 2 and two type 1 defective interfering particle RNAs, and fingerprint of the poliovirus type 3 genome. Journal of General Virology 44:311–322
NakanoJ. H.,
GelfandH. M.,
ColeJ. T.1963; The use of a modified Wecker technique for the serodifferentiation of type 1 polioviruses related and unrelated to Sabin’s vaccine strain. II. Antigenic segregation of isolates from specimens collected in field studies. American Journal of Hygiene 78:214–226
NakanoM.,
MatsukuraT.,
YoshiiK.,
KomatsuT.,
MukoyamaA.,
UchidaN.,
KodamaH.,
TagayaI.1979; Genetical analysis on the stability of poliovirus type 3 Leon 12 a1b. Journal of Biological Standardization 7:157–168
NomotoA.,
KajigayaS.,
SuzukiK.,
ImuraN.1979; Possible point mutation sites in LSc 2ab poliovirus RNA and a protein covalently linked to the 5′-terminus. Journal of General Virology 45:107–117
NottayB. K.,
KewO. M.,
HatchM. H.,
HeywardJ. T.,
ObijeskiJ. F.1981; Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology 107:405–423
PalmenbergA. C.,
PallanschM. A.,
RueckertR. R.1979; Protease required for processing picornaviral coat protein resides in the viral replicase gene. Journal of Virology 32:770–778
RueckertR. R.,
MatthewsT. J.,
KewO. M.,
PallanschM. A.,
McleanC.,
OmilianowsklD.1979; Synthesis and processing of picornaviral polyprotein. In Molecular Biology of Picornaviruses pp 113–125 Edited by
Perez-BercoffR.
New York: Plenum Press;
SabinA. B.1957; Properties and behaviour of orally administered attenuated poliovirus vaccine. Journal of the American Medical Association 164:1216–1223